PDCD1 and neoplasm: PD-L1 expression levels within the tumor microenvironment can predict treatment responses to monotherapies blocking the PD-L1/PD-1 axis in different tumor types 34-36, which are regulated in highly complex manners and can be influenced by transcriptional control and posttranslational regulation 37.